# Incision

> Amsterdam hospital software provider helping operating-room and sterile-processing teams prepare for procedures.

## Why it is interesting

HERAN HealthTech Fund II announced a €4M investment on November 10, 2026 for U.S. expansion; the announcement does not assign it a Series A/B stage. Incision sells a workflow and knowledge platform to hospitals rather than consumer medical advice.

## Profile

- **Latest funding:** Not publicly disclosed
- **Latest known valuation:** Not publicly disclosed
- **Total disclosed equity funding:** Not publicly disclosed
- **Stage:** other
- **Status:** private
- **Industries:** N/A
- **Coverage:** full
- **Last updated:** 2026-11-13

## Key facts

- HERAN GP reports €4M invested November 10, 2026, its Fund II's third investment; no named venture-round stage.
- Investor says about 300 hospitals / 20+ countries use Incision products; not independently audited.
- Case-study outcomes include 15% faster turnovers; selected vendor-reported cases should not be generalized.

## Funding history

- HERAN HealthTech Fund II investment; stage undisclosed · €4M reported investment; instrument, valuation and other investor allocations undisclosed · November 10, 2026
  Source: https://www.heranpartners.com/news-insights/incision-investment

**By:** [Venture Capital Tracker](https://venturecapitaltracker.com/editorial-policy)
**Last updated:** November 13, 2026

**Editorial note:** AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.

---
Source: https://venturecapitaltracker.com/startup/incision